Document is current

Any future updates will be listed below

NEK2 promotes oral squamous cell carcinoma progression and serves as a diagnostic and therapeutic target

Crossref DOI link: https://doi.org/10.1038/s41598-026-47174-6

Published Online: 2026-04-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark